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Abstract 1 
 2 
Background: Although itch and pain are distinct experiences, both are unpleasant, and may demand 3 
attention and interfere with daily activities. Research investigating the role of attention in tonic itch and 4 
pain stimuli, particularly attentionalwhether attention is drawn to at the stimulus location, is scarce.  5 
Methods: In the somatosensory attention task, fifty-three healthy participants were exposed to 35-6 
seconds electrical itch or pain stimuli on either the left or right wrist. Participants responded as quickly as 7 
possible to visual targets appearing at the stimulated location (ipsilateral trials) or at the arm without 8 
stimulation (contralateral trials). During control blocks, participants performed the visual task without 9 
stimulation. Attention allocation al prioritization at the itch andor pain location is inferred when 10 
responses are faster ipsilaterally than contralaterally. 11 
Results: Results did not indicate that attention was directed towards or away from the itch and pain 12 
location. Notwithstanding, participants were slower during itch and pain than during control blocks.  13 
Conclusions: In contrast with our hypotheses, no indications were found for spatial attention allocation 14 
towards the somatosensory stimuliattention was not prioritized at the itch and pain location. This may 15 
relate to dynamic shifts in attention over the time course of the tonic sensations. Our secondary finding 16 
that itch and pain interfere with task performance is in line with attention theories of bodily perception.  17 
 18 
 19 
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1. Introduction  1 
 2 
Itch and pain are common somatosensory sensations, which, in acute form, function to protect body 3 
integrity, e.g., penetration of the skin or stinging insects [1]. When chronic, e.g., due to chronic 4 
inflammatory conditions of the skin, joints or viscera, they often have a serious impact on quality of life 5 
and performance in daily activities [2-4]. One of the primary reasons for this burden is that itch and pain 6 
demand attention in order to perform their protective role [1, 5-7]. For example, when we touch a sharp 7 
object or red ants crawl on our skin, fast detection and identification of the threat along with 8 
interruption from a concurrent task is adaptive as we can impose action to prevent bodily damage. The 9 
interplay between attention and pain has frequently been investigated. The interplay between attention 10 
and itch, however, has barely received attention.  11 
 12 
Leading cognitive frameworks on pain, which might to some extent also apply for itch, propose that pain 13 
draws attention and as such interrupts ongoing task performance and goal pursuit [7-12]. Overall, 14 
studies indicate that patients with chronic pain attend more to pain related stimuli than control 15 
participants, and have difficulties disengaging their attention away from pain [5, 6]. Such impaired ability 16 
to disengage attention from pain or pain-related information is believed to detrimentally affect 17 
functioning in daily activities [5-7]. Pain interferes with task performance [13-19], probably by directing 18 
attention to the location where the pain is expected and/or experienced. More recently, studies have 19 
focused upon the spatial prioritization of attention allocation in pain [20-28]. It was found that attention 20 
was directed to the bodily location where threatening somatosensory stimuli were expected to occur 21 
[24-26]. It is reasonable to assume that individual differences in catastrophizing, worrying, and pain 22 
related fear amplify the threat value of somatosensory stimuli, and thus lead to a stronger prioritization 23 
of attention [5, 16, 29-33]. Also attempting to control pain, leads to a similar allocation prioritization of 24 
attention towardsat the location where somatosensory stimuli awere expected to occur [22, 27]. A 25 
heightened level of attention for pain and its location may then intensify the pain sensation or its impact 26 
upon daily functioning This prioritization of spatial attention is akin to an attentional bias (see [5]), and is 27 
assumed to worsen the pain sensation [5, 27]. These processes may also play a role in patients with 28 
chronic itch or pain [9, 10, 34, 35]. With regard to attention and itch, there are only some indications 29 
that itch-related information (e.g., words or pictures) draws attention [36-39] and that more bodily 30 
attention is related to heightened itch sensitivity [40]. However, research into spatial allocation of 31 
attention while experiencing itch is limited [39]. 32 
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 2 
 The investigation of spatial attention in pain and itch requires the use of specific paradigms. For 3 
example, spatial attention allocation has been investigated while participants perceive somatosensory 4 
pain stimuli on different locations while focusing on and responding to the location of 5 
tactile/visual/auditory target stimuli that are ipsilateral or contralateral to the pain location (e.g., [20-6 
28]). Prioritization of aAttention allocation to  at the stimulation location is inferred when participants 7 
respond faster to visual targets displayed ipsilaterally than on targets displayed contralaterally to 8 
stimulation, as can be deduced from the attentional bias index (i.e. the difference in response time to 9 
the contralateral minus the ipsilateral targets [21]). Enhanced focusing on the ipsilateral location is 10 
indicative for an attentional engagement, whereas faster responses on the contralateral location are 11 
indicative for disengagement of attention away from the stimulus, and when the attentional bias index 12 
significantly deviates from zero, there is an attentional bias. It has generally been found that pain draws 13 
attention towards its location, i.e. attentional engagement [20-28]. Most of these studies, with the 14 
exception of [28], use phasic stimuli (≤ 1 s). However, patients often experience symptoms for a longer 15 
duration, stressing the importance of being able to disengage attention from pain and focus on activities 16 
in daily life. This is not only relevant for the study of pain, but also for itch, which is a sensation that is 17 
often prolonged by attentional processes, given its contagiousness [41]. For itch, we developed a 18 
somatosensory attention task (SAT) [39] with tonic itch stimuli of 35 s during which participants 19 
responded as quickly as possible to visual targets located at the stimulated or non-stimulated location. 20 
We did not find that healthy participants focused their attention towards the itch location, instead, we 21 
found some indications that participants disengaged their attention away from the itch location during 22 
the second half of the 35-s itch stimuli [39]. However, given the discrepancy with previous findings for 23 
pain showing that pain draws attention to its location, additional research involving both tonic itch and 24 
pain is required.  25 
The aim of the present study was to investigate whether healthy participants focus their 26 
attention at or away from the tonic itch and pain stimulus location. It was expected that the participants’ 27 
would prioritize attention would be drawn atto the location of the itch and pain stimuli early on, but 28 
later on during the stimulation, would disengage their attention from the stimulated location. 29 
Additionally, the relationship between attentional processing of itch and pain and other psychological 30 
characteristics, specifically self-reported catastrophizing, neuroticism, perceived threat of the 31 
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somatosensory stimuli, attention for bodily sensations, and attentional disengagement from itch and 1 
pain was explored.  2 
 3 
 4 
2. Methods 5 
 6 
Participants 7 
Fifty-three healthy volunteers (45 female/ 8 male; mean age of22.0 years, SD = 2.2; range 18.6–29.4 8 
years) were included. Participants were recruited through advertisements at Leiden University and the 9 
Leiden University Research Participation system (SONA systems Ltd, Tallinn, Estonia). Inclusion criteria 10 
for participation were being aged between 18 and 30 years (with the intention to include a homogenous 11 
group since reaction times increase with age [42]) and fluent in Dutch language. Exclusion criteria for 12 
participation were being a patient with chronic itch or pain, severe morbidity (e.g., multiple sclerosis, 13 
diabetes mellitus, heart or lung disease, vasculitis), psychiatric disorders (e.g., depression), use of 14 
pacemaker, current use of medication (e.g., analgesics, antihistaminics), and pregnancy. Of the 15 
participants, 73.6% was following or had finished tertiary education, 24.5% was following or had finished 16 
secondary education, and 1.9% had followed primary education. The protocol was approved by the local 17 
Medical Review Ethics Committee and all participants provided written informed consent prior to 18 
testing. 19 
 20 
Itch and pain induction 21 
Itch and pain were induced electrically by means of a constant current stimulator (Isolated Bipolar 22 
Constant Current Stimulator DS5, Digitimer, United Kingdom) [38, 43]. For itch induction, two surface 23 
electrodes were attached to the center of the lateral side of the wrist, a disk electrode (ø 1 cm, VCM 24 
Medical, the Netherlands) 1.5 cm proximal to the triquetrum, and a reference electrode (ø 2 cm, VCM 25 
Medical, the Netherlands) 2 cm proximal [38, 43]. For pain induction, two surface electrodes (two disk 26 
electrodes of ø 1 cm, VCM Medical, the Netherlands) were attached at the center of the dorsal side of 27 
the wrist [21], one 1.5 cm proximal to the processus styloides ulnae, the other 2 cm proximal. In 28 
accordance with our previous studies with electrically induced itch [38, 43], the stimulus characteristics 29 
for the itch stimuli were 50 Hz frequency, 0.1 ms pulse duration, and a ramping of 0.05 mA/s. The itch 30 
stimuli lasted for at maximum 35 seconds, the duration of the stimuli in the SAT. For pain, the stimulus 31 
characteristics were partly based on previous studies (e.g., [25, 44]) and partly determined by extensive 32 
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piloting of the methods since electrical pain stimuli are not regularly applied for 35 seconds. Eventually, 1 
pain stimuli were applied also at 50 Hz frequency and 0.4 ms pulse duration. Alike our previous studies 2 
[38, 43], the maximum current for all stimuli was 5.00 mA. The levels of itch and pain evoked by each 3 
electrical stimulus were scored on a numerical rating scale (NRS) ranging from 0 (no itch/pain) to 10 4 
(worst itch/pain ever experienced).  5 
 6 
Determination of the intensity of the itch stimuli: In order to determine the individual intensity at 7 
which the 35-s baseline itch stimulus and the itch stimuli during the SAT were delivered, a step-up 8 
procedure was executed with 35s stimuli starting at 0.25 mA, with 0.50 mA increments for every step. 9 
For example, the first stimulus started at 0.25 mA and, as a consequence of the ramping, ended at 2.00 10 
mA, the second started at 0.75 mA and ended at 2.50 mA. Because the first step ended relatively high, 11 
just before the itch step-up, familiarization with the stimulation took place by assessing two perception 12 
thresholds starting at 0.01 mA and ending when the participant reported “the moment that you 13 
experience a sensation for the first time” [43]. The step-up procedure finished when the aimed NRS itch 14 
was at least 5 or the maximum defined current intensity of 5.00 mA was reached (i.e. stimulus from 3.25 15 
to 5.00 mA). However, in the case the NRS itch exceeded 7, the current intensity was decreased with 0.5 16 
mA (when NRS itch ≥ 8) or 0.25 mA (when NRS itch ≥ 7) up until the NRS itch was between 5 and 7. In 17 
this study, the determined starting current intensity for the baseline and SAT itch stimuli was on average 18 
2.36 (SD=1.26) mA.  19 
 20 
Determination of the intensity of the pain stimuli: In order to determine the individual intensity 21 
at which the 35-s baseline pain stimulus and the pain stimuli during the SAT were delivered, a step-up 22 
procedure was executed with 10s stimuli (in order to keep stimulation time better comparable to the 23 
itch step-up procedure which consisted of less steps) that increased by 0.50 mA per step. The first 24 
stimulus was given at 0.50 mA, the second at 1.00 mA, etc. The step-up procedure finished when the 25 
aimed NRS pain was at least 5 or the maximum defined current intensity of 5.00 mA was reached. 26 
However, in the case the NRS pain exceeded 7, the current intensity was decreased with 0.5 mA (when 27 
NRS pain ≥ 8) or 0.25 mA (when NRS pain ≥ 7) up until the NRS pain was between 5 and 7. In this study, 28 
the determined current intensity for the 35-s baseline pain stimulus before the SAT and the pain stimuli 29 
during the SAT was on average 3.70 (SD=1.59) mA.  30 
 31 
Somatosensory attention task 32 
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The somatosensory attention task (SAT) as used in our previous study [39], which was based on an 1 
attention task developed for pain [21], was adopted to investigate attention allocation al prioritization at 2 
towards both an itch and pain stimulation and their location (see Fig. 1 for a schematic representation of 3 
the setup). A plastic black curved screen of ca. 50 cm height with 3 LED lights at 10 cm height (middle 4 
green fixation LED, the left and right were red target LEDs placed at 25 degrees from the middle LED) was 5 
placed in front of the participant. The LEDs were controlled using E-prime software version 2.0 6 
(Psychology Software Tools Inc., Sharpsburg, PA, USA) on a Dell optiplex 3010 computer with Philips 7 
Brilliance 225 TFT screen (Resolution 1280x1024 at 60 Hz). Right below the left and right LED there was a 8 
platform with finger response buttons (Pushbutton Switch, SPDT, Off-(On)) at a fixed position, attached 9 
to a serial response box (Psychology Software Tools Inc. Sharpsburg, PA, USA). 10 
The SAT consisted of 12 blocks of 35 seconds each, of which 4 blocks with pain stimuli (pain 11 
blocks), 4 blocks with itch stimuli (itch blocks), and 4 blocks without somatosensory stimulation (control 12 
blocks). The order of blocks was randomized by E-Prime for each participant. The standard interval 13 
between two blocks was 1 minute, which was extended by 1 minute up to a maximum of 5 minutes in 14 
the case the NRS pain or NRS itch exceeded 2.0. During each block 10 trials with visual targets were 15 
administered, in which first the fixation light (green LED light) was turned on for 1000 ms, extinguished, 16 
and then either the left or right target (red LED light) was turned on for 200 ms [39], while unilaterally 17 
administering itch (itch blocks), pain (pain blocks) or no stimulation (control blocks). The response 18 
window for participants to press a button was 1500 ms. The 10 target stimuli in each block were given in 19 
random order with random time interval (varying between 0 and 2000 ms) before the next trial. Half of 20 
the visual targets were presented at wrist where the electrodes were attached and itch or pain was 21 
applied in the case of itch and pain block respectively (“ipsilateral trials”) and half of the visual targets 22 
were presented oppositely (“contralateral trials”). Conform previous research (e.g., [21]), the difference 23 
in participants’ responding to ipsilateral versus contralateral trials is a measure of spatial attention 24 
allocation towards the somatosensory stimuli, with faster responses to ipsilateral trials being indicative 25 
for an attentional bias. 26 
 27 
<DISPLAY FIG. 1 ABOUT HERE> 28 
 29 
Self-report questionnaires 30 
The following self-report questionnaires were administered in Dutch using the online system Qualtrics 31 
(Provo, Utah, USA).  32 
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The presence of physical symptoms was assessed by visual analogue scales (VAS) for itch and pain 1 
from the Impact of chronic skin disease on daily life (ISDL) [45], inquiring about the levels of itch and pain 2 
during the past two weeks on a scale from 0 (no itch/pain) to 10 (worst itch/pain experienced). 3 
Psychological distress was measured with the Hospital Anxiety and Depression Scale (HADS) [46] 4 
and a short version of the Positive and Negative Affect Schedule (PANAS) [47]. The HADS consists of 7 5 
items measuring the subscale depression (Cronbach alpha 0.67) and 7 items measuring the subscale 6 
anxiety (Cronbach alpha 0.71), scored on a scale from 0 to 3. The total score was obtained by summing 7 
the items per subscale. The PANAS consists of 5 positive items (PANAS-PA; Cronbach alpha 0.59) and 5 8 
negative items (PANAS-NA; Cronbach alpha 0.35) scored on a 5-point Likert scale from 1 to 5. Due to the 9 
low reliability, the PANAS was excluded from data analyses.  10 
Catastrophizing about physical sensations was measured using the Pain Catastrophizing Scale 11 
[48], adjusted for physical sensations (PCS-A) in order to make it also applicable to itch (i.e. by 12 
substituting the word “pain” for “physical sensations” for all concerning items). The questionnaire 13 
contained 13 items, which were scored on a 5-point Likert scale from 0 to 4. The Cronbach alpha for the 14 
PCS-A in the present study was 0.87. 15 
Neuroticism was measured with the Eysenck Personality Questionnaire revised short scale (EPQ-16 
RSS) [49], consisting of different subscales, including the subscale neuroticism (Cronbach alpha=0.72), 17 
which consists of 12 items rated on a dichotomous scale (yes = 1 /no = 0).  18 
Fear of pain was measured using the Fear of Pain Questionnaire III (FPQ-III) [50], with 30 items 19 
assessing the degree of fear participants would likely experience in potentially painful situations, 20 
subdivided in the categories severe pain, minor pain, and medical pain. The items are rated on a 5-point 21 
scale from 1 (not at all fearful of this pain) to 5 (extremely fearful of this pain). Cronbach alpha of the 22 
FPQ-III in the present study was 0.90. 23 
Attentional focus on bodily sensations was measured using the Body Vigilance Scale (BVS) [40, 24 
51], the Body Sensations questionnaire [40, 52], and the Pain Vigilance and Awareness Questionnaire 25 
[53] adjusted for physical sensations (i.e. by substituting the word “pain” by “physical sensations” for all 26 
concerning items) (PVAQ-A) in order to make it broadly applicable to physical sensations, including itch 27 
and pain. The BVS, used to measure attentional focus on bodily sensations, contained 4 items, of which 28 
the fourth item consisted of 13 sub-items about anxiety-related bodily sensations. All items were rated 29 
on a VAS from 0 to 10. Cronbach alpha of the BVS in the present study was 0.79. Additionally, two items 30 
had been added that assess one’s attention directed towards itch and pain. Of the BSQ, the 15 items 31 
concerning bodily sensations (omitting the 2 items concerning derealization) were used to measure of 32 
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attentional focus on the occurrence of bodily sensations when in a nervous or feared situation (e.g., 1 
heart palpitations, dizziness or sweating). Participants used a 5-point Likert scale that ranged from “the 2 
sensation never occurs” (0) to “the sensation occurs almost always or always” (4). Cronbach alpha of the 3 
BSQ in the present study was 0.79. The PVAQ-A was used to measure attention to bodily sensations by 4 
asking subjects to consider their behavior in relation to physical sensations. The PVAQ-A (Cronbach alpha 5 
0.85) consisted of 16 items, e.g., ‘I focus on physical sensations’. Items were scored on a 6-point Likert 6 
scale (0 never to 5 always).  7 
Attentional disengagement from itch and pain was assessed using two Likert scales ranging from 8 
1 (not at all able to disengage attention) to 5 (always able to disengage attention).  9 
 10 
In addition to these online questionnaires, participants indicated the perceived threat of the stimuli 11 
experienced used in the experiment on a scale from 0 (not threatening) to 10 (very threatening). 12 
Participants also rated the extent to which they were distracted by the itch or pain stimuli or other 13 
factors during their responses to the visual targets in the SAT on 5-point Likert scales ranging from 1 (not 14 
at all distracted) to 5 (distracted to very large extent). 15 
 16 
Procedure 17 
Potential participants were informed about the study via written information. When interested in 18 
participation, they clicked on a link to fill out the questions concerning demographic variables, absence 19 
or presence of medical or psychiatric conditions, intake of medication during the past 4 weeks, and 20 
above-mentioned questionnaires: VAS for itch and pain, HADS, PANAS, PCS-A, EPQ-RSS, FPQ-III, BSQ, 21 
PVAQ-A, and attentional disengagement from itch and pain. Based on the online assessment, eligibility 22 
screening was performed on in- and exclusion criteria. Uncertainties about eligibility were solved by 23 
telephone contact. Eligible participants made an appointment for participation. Participants were 24 
instructed to refrain from intake of alcohol and drugs 24 hours before attending the experiment. Upon 25 
arrival at the test facility, participants were verbally informed about the procedure and told that they 26 
were free to terminate the experiment at any time. Then participants signed the informed consent. In 27 
the lab, subjects also rated their current levels of spontaneous itch and pain on an NRS ranging from 0 28 
(no itch/ pain) to 10 (worst itch/pain ever experienced) and filled out the BVS and PANAS.  29 
 30 
In order to standardize the participants’ wrist temperature, which could influence electrical conductivity 31 
[54], subjects held their wrists for 3 minutes in a warm water bath made at 34°C [see also [38, 43], 32 
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before the electrical stimulation. The side of itch and pain stimulation (left and right wrist or vice versa) 1 
was randomized across participants. Then, the step-up procedures for itch and pain were carried out in 2 
random order to determine the individual intensity of the itch and pain stimuli. At the individually 3 
determined intensity, baseline itch and pain stimuli were applied for 35 seconds. Right before the SAT, 4 
participants were asked to position their index fingers of the left and right hand on the left and right 5 
response button, respectively. They were instructed to focus on the visual stimuli and to respond as 6 
quickly as possible to the location of a target LED illuminating, by pressing the response button at the 7 
ipsilateral side. Before each block, participants were informed whether they would receive a pain 8 
stimulus (i.e., pain block), an itch stimulus (i.e., itch block), or no stimulus at all (i.e., control block). At the 9 
start of each block, the experimenter counted down from 3 to 0, to indicate the onset (at 0) of a block. 10 
Directly following each block, participants were asked to retrospectively report the levels of itch and pain 11 
that were evoked (irrespective of any ongoing spontaneous itch or pain) during the block on NRSs 12 
ranging from 0 (no itch/pain) to 10 (worst itch/pain ever experienced). After all measurements, 13 
participants indicated the perceived threat of the itch and pain stimuli and the extent to which they were 14 
distracted during their task performance to respond to the visual targets. After a short debriefing, 15 
participants received a monetary reimbursement. 16 
 17 
Statistical analyses 18 
Reaction times (RT) for trials with RT ≥ 150 ms (0.2% of the RT were excluded) and trials with correct 19 
responses (0.6% of the RT were excluded) were extracted from E-prime. Data of two participants were 20 
excluded [fire alarm evacuation (n=1), problems with itch stimulation (n=1)] because ≤70% of the RT data 21 
was available [39]. Using Matlab and Statistics Toolbox Release 2012b (The MathWorks, Inc., Natick, 22 
Massachusetts, United States) the mean RT per trial type (ipsilateral and contralateral trials during pain, 23 
itch, and control blocks) were calculated per participant. Accuracy for the SAT was checked, and none of 24 
the participants had to be removed based on the criterion of > 30% mistakes [39]. Additionally, RT per 25 
trial type were calculated for three consecutive time segments of the 35-s SAT blocks. Three was the 26 
maximum number of segments the blocks could be split into to remain sufficient observations per trial 27 
type. 28 
 29 
All variables to be included in the statistical analyses were checked for normal distribution and 30 
transformed when necessary. Transformation did not result in normal distribution of the NRS itch and 31 
pain scores during the control blocks and assumptions for the majority of psychological characteristics 32 
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were not met. In addition, there were two participants displaying outlying RT (i.e. >3 SD of the overall 1 
mean) for the majority of the trial types. Therefore, the analyses were conducted both in all 51 2 
participants, and after excluding the two outliers (n=49) combined with log-transformed variables.  3 
 4 
A manipulation check, to confirm that the intended sensations had been induced in the respective 5 
blocks, was conducted comparing the NRS itch and pain scores for the itch and pain blocks, respectively, 6 
to the control blocks using non-parametric Sign tests. Similarly, NRS unpleasantness ratings were 7 
exploratorily compared across the different block types. An attentional bias index (AB-index) was 8 
calculated for itch and pain [21] using the formula RTcontralateral – RTipsilateral, during itch and pain blocks, 9 
respectively. A positive AB-index indicated that attention was directed ipsilaterally to the stimulus 10 
location (attentional disengagement), while a negative AB-index indicated that attention was directed 11 
contralaterally to the stimulus location (attentional disengagement). One-samples t-tests were 12 
conducted to assess whether the AB-indices significantly differed from zero, i.e. implying attentional 13 
bias. In order to test the main hypothesis of whether participants focused attention on the itch and pain 14 
location, two repeated measures analyses of variance (RM-ANOVAs) were carried out with the within-15 
subjects factors location (ipsilateral vs. contralateral) and block type (either itch or pain vs. control). 16 
Separate analyses for itch and pain were required because location in the control blocks referred to the 17 
location of the attached itch and pain electrodes, which were oppositely attached, and, consequently, 18 
for control blocks, the ipsilateral location was indecisive. Main effects of location and block type were 19 
calculated, as well as location x block type interactions. Exploratorily, a similar RM-ANOVA was 20 
conducted to compare the RT for the itch versus pain blocks (control blocks were not included). In order 21 
to investigate the course of attention allocation over time, 2x2x3 RM-ANOVAs were conducted, for itch 22 
and pain separately, with the within-subjects factors location (ipsilateral vs. contralateral), block type 23 
(either itch or pain vs. control) and time (first segment, second, and third time segment of blocks). Main 24 
effect of time and location x block type x time interactions were calculated. For all RM-ANOVAs, a 25 
generalized eta squared was calculated [55, 56]. 26 
 27 
Finally, Pearson correlation coefficients were calculated between the AB-indices for itch and pain. Non-28 
parametric correlation coefficients (Spearman) were calculated between the psychological 29 
characteristics (EPQ-RSS-n, BVS, BSQ-f, PVAQ-A, PCS-A, FPQ-III, attentional focus on and disengagement 30 
from itch and pain, and perceived threat of the stimuli) and itch and pain AB-indices [21].  31 
 32 
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Statistical analyses were conducted using SPSS 23.0 software (IBM SPSS Statistics for Windows, Armonk, 1 
NY, USA). All values displayed are means ± SD, unless stated otherwise. A p < 0.05 was considered 2 
statistically significant. 3 
 4 
 5 
3. Results 6 
 7 
Participants 8 
The baseline levels of itch, pain and fatigue and outcomes of self-report questionnaires measuring the 9 
psychological characteristics of the 53 participants included are displayed in Table 1. The reasons for 10 
baseline spontaneous itch levels >0 (n=10 in total, MNRS-itch>0= 1.1 ±0.5, ranging from 0.5 to 2.0) were 11 
talking/thinking about itch as a result of this specific question (n=5), dry skin (n=2), sweating due to 12 
traveling (n=1), epilated armpit (n=1), some skin irritation (n=1). The reasons for baseline spontaneous 13 
pain levels >0 (n=8 in total; MNRS-pain>0= 1.1 ±0.5, ranging from 0.3 to 2.0) were sore throat (n=2), muscle 14 
ache (n=2), back ache (n=1), knee pain resulting from surgery some weeks ago (n=1), menstruation pain 15 
(n=1), and finger cut (n=1). 16 
 17 
<DISPLAY TABLE 1 ABOUT HERE>  18 
 19 
Manipulation check: induced itch and pain 20 
The itch, pain, and unpleasantness scores for the baseline itch and pain stimuli and those during the SAT 21 
blocks are displayed in Table 2. Non-parametric Sign tests showed that median NRS itch scores were 22 
significantly higher during itch than control blocks of the SAT and median NRS pain scores were 23 
significantly higher during pain than control blocks (both p<0.0001). Median NRS unpleasantness scores 24 
were significantly higher during itch and pain blocks than during control blocks (both p<0.0001) and also 25 
significantly higher during pain blocks than during itch blocks (p<0.0001).  26 
 27 
Perceived threat of the stimuli 28 
The induced pain and itch were, on average, perceived as 2.8 ± 2.4 and 1.5 ± 1.8 threatening, 29 
respectively. With regard to the degree to which participants were distracted from the task to respond 30 
to the visual targets, they indicated to be distracted by the itch and pain stimuli on average 3.2 ± 1.0 and 31 
2.5 ± 1.1 respectively and 1.8 ± 0.6 by other factors.  32 
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 1 
<DISPLAY TABLE 2 ABOUT HERE>  2 
 3 
Behavioral outcomes 4 
With regard to the accuracy, the average number of mistakes made during the SAT over all participants 5 
was 0.6 ± 1.3 (range 0 to 8; theoretical maximum 120), with overall 0.5% mistakes during itch blocks, 6 
0.4% mistakes during pain blocks, and 0.6% mistakes during control blocks. The mean RTs during itch, 7 
pain, and control blocks for the ipsilateral and contralateral trials are displayed in Table 3.  8 
 9 
<DISPLAY TABLE 3 ABOUT HERE> 10 
 11 
Of primary interest to this study was the location x block type interaction effect as this indicated whether 12 
attention was prioritized drawn to the stimulus location. For itch, the RM-ANOVA comparing the 13 
ipsilateral and contralateral trials (factor 1: location) during the itch and control blocks (factor 2 block 14 
type) did not show a significant location x block type interaction effect (F(1,50)=0.78, p=0.38, G
2 15 
=0.0014). There was, however, a significant main effect of block type (F(1,50)=12.80, p< 0.001, G
2 16 
=0.019), with longer RT for itch blocks than control blocks. The main effect of location was not significant 17 
(F(1,50)=0.13, p=0.72, G
2 =0.0003). For pain, the RM-ANOVA did not show a significant interaction effect 18 
of location x block type (F(1,50)=0.71, p=0.41, G
2 = 0.00012). Again, there was a significant main effect 19 
of block type (F(1,50)=21.29, p< 0.0001, G
2 =0.05), with longer RT for pain blocks than for control blocks, 20 
but no significant main effect of location (F(1,50)=0.16, p=0.69, G
2 =0.00032).After removing the two 21 
outliers, similar levels of significance were obtained. In line with the main findings of the non-significant 22 
location x block type interaction, no significant attentional biases were found as the AB-indices for itch 23 
(t(50) = -0.51, p=0.61) and pain (t(50) = 0.18, p=0.86) did not significantly differ from zero. 24 
 25 
Explorative comparison of the itch and pain blocks showed no significant interaction effect of location x 26 
block type (F(1,50)=0.13, p=0.72, G
2 =0.00036), nor a significant main effect of location (F(1,50)=0.004, 27 
p=0.952, G
2 =0.00001), but the overall RT were significantly longer for the pain than for the itch blocks 28 
(F(1,50)=5.26, p=0.026, G
2 =0.0109).  29 
 30 
  31 
14 
 
Time course of attention during the SAT 1 
In a further analysis of the data, Fig. 2 displays the RT for the ipsilateral and contralateral trials during the 2 
itch (Fig 2A), pain (Fig 2B) and control (Fig. 2C) blocks, which are subdivided into three equal time 3 
segments. For itch, there was no significant location x block type x time interaction (F(2,100) = 2.01, 4 
p=0.140, G
2 = 0.0068), but a significant main effect of time (F(2,100) = 3.77, p=0.026, G
2 = 0.015) 5 
emerged. Simple contrast analyses showed that RT were significantly faster in the second than in the 6 
first segment (F(1,50) =6.73, p=0.012, G
2 = 0.006). There were no significant differences in RT when 7 
comparing the second with the third segment, although a non-significant trend was observed (F(1,50) 8 
=4.03, p=0.050, G
2 = 0.038), or when comparing the first and the third segment (F(1,50) =0.48, p=0.494, 9 
G
2 =0.0094). For pain, there was no significant location x block type x time interaction (F(2,100) = 0.41, 10 
p=0.662, G
2 = 0.0012), nor a significant main effect of time, although a trend was observed (F(2,100)= 11 
2.99, p=0.055, G
2 = 0.012).  12 
 13 
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 15 
After removing the two outliers, similar results were obtained in the 2x2x3 RM-ANOVA for itch. For pain 16 
results were also comparable after removing the two outliers, although now a significant main effect of 17 
time (F(2,96)= 3.17, p=0.047, G
2= 0.015) was found. Simple contrast analyses showed significantly faster 18 
RT in the second than in the first segment (F(1,48)=7.30, p=0.010, G
2 =0.026), but no significant 19 
differences in the second compared to the third segment (F(1,48)=1.43, p=0.237, G
2=0.011) nor in the 20 
first compared to the third segment (F(1,48) =1.54, p=0.221, G
2 =0.019).  21 
 22 
Exploratory analyses: Association between individual characteristics and attentional bias towards itch 23 
and pain 24 
The AB-index for itch was on average -2.9 ± 39.9 and ranged from -80.1 to 90.2; 39.2% of the participants 25 
displayed a positive AB-index (i.e. towards the itch stimulus location). The AB-index for pain was on average 26 
1.0 ± 41.0 and ranged from -79.5 to 86.5; 54.9% of the participants displayed a positive AB-index (i.e. 27 
towards the pain stimulus location). The AB-indices for itch and pain were not significantly correlated (R= -28 
.252, p=0.074). The AB indices were generally not significantly correlated with the psychological 29 
characteristics neuroticism (EPQ-RSS), catastrophizing of physical sensations (PCS-A), fear of pain (FPQIII), 30 
self-reported attention to itch and pain and to bodily sensations in general (BVS, BSQ-f, PVAQ-A), 31 
attentional disengagement from itch and pain, and the perceived threat of the itch and pain stimuli. Only 32 
15 
 
four significant correlations were observed. There were positive associations between the AB-index for itch 1 
on the one hand and catastrophizing (rS = 0.40, p=0.003), neuroticism (EPQ-RSS-n) (rS = 0.37, p = 0.008), and 2 
the threat value of the itch stimulus (rS = 0.29, p=0.04) on the other hand. There was a negative association 3 
between the AB-index for pain the threat value of the pain stimulus (rS =-0.30, p= 0.03).  4 
 5 
 6 
4. Discussion 7 
 8 
The present study investigated whether attention of healthy volunteers would be spatially drawn 9 
prioritized to the spatialto the stimulus location of stimulation early on during tonic itch and pain stimuli, 10 
and, whether they would disengage their attention away from the stimulated location later on during 11 
stimulation. In the somatosensory attention task, participants received tonic somatosensory itch or pain 12 
stimuli, or no stimulation while responding to the location of visual targets, either ipsi- or contralaterally 13 
displayed to the somatosensory location. In contrast with our ideas, no significant differences were 14 
found between responding to visual targets ipsilaterally compared to contralaterally to the stimulation, 15 
neither over the total duration of stimulation nor across the three successive time segments during the 16 
tonic itch and pain stimuli. Of further note, we observed that itch and pain stimulation slowed down 17 
participants’ task performance (i.e. responding to visual targets) compared to no stimulation, indicating 18 
towards attentional interference by itch and pain. Overall, these results seem to indicate that itch and 19 
pain affect attentional processes, but that attention is not systematically directed towards nor 20 
disengaged from the location of tonic itch and pain stimulation.  21 
 22 
There were no indications that attention was directed away from or towards the location of the itch and 23 
pain stimulation: reaction times for ipsilateral and contralateral trials did not significantly differ, nor was 24 
there a significant difference in spatial attention allocation between itch and pain. The indications for an 25 
attentional disengagement effect during the last part of the 35 s itch stimulation in our previous study 26 
[39] could not be confirmed here. In addition, we were also not able to replicate previous findings that 27 
pain directs attention towards its spatial location [20-28]. However, most of these studies used phasic 28 
pain stimuli with each trial consisting of one pain stimulus and one target stimulus [20-27] or pain stimuli 29 
of maximally 10 seconds [28]. It could be that the 35 s somatosensory stimuli in the present study along 30 
with multiple trials of visual targets during that stimulus may not draw attention to the stimulus location 31 
for the entire time frame. Attention likely continuously shifted between the somatosensory stimuli and 32 
16 
 
visual targets. This process may have been enhanced because the participants were aware that the visual 1 
targets could be displayed ipsilateral or contralateral to the stimulation and the central fixation light 2 
before each trial could have influenced attention allocation. Moreover, the intensity of the itch and pain 3 
stimuli as well as the threatening character of the stimuli was relatively mild, and therefore the stimulus 4 
saliency may have been limited. Generally, in the present and the previous study there was a time effect 5 
showing that participants responded faster after the first segment. This may be owing to a learning 6 
effect as the participants learned to respond faster to the visual targets, leaving less attention to focus 7 
on the itch and pain sensations. This effect was, however, irrespective of the spatial location of the 8 
somatosensory stimuli. It could be that somatosensory stimuli only draw attention to the spatial location 9 
in the very beginning, but clearly still result in attentional interference. The current segmentation of 10 
three time segments might not be sufficiently fine-grained to determine continuous attentional shifts.  11 
 12 
Of further note, our study did show that participants were generally slower in task performance of 13 
responding to the targets during itch and pain, which is indicative for attentional interference by itch and 14 
pain. That pain interferes with attention previously been demonstrated [13-19] although most studies 15 
used stimuli with a duration shorter than 35 s. Surprisingly, in our previous study with itch stimuli similar 16 
to those in the present study we did not find such an interference effect [39]. Exploratory findings 17 
indicate that pain may interfere more in attentional processing than itch, as overall reaction times (i.e. 18 
independent of stimulus location) were slower during pain than during itch. Explanations for this may 19 
include that pain is evolutionarily more aversive, as indicated by the higher reported threat value and 20 
unpleasantness of the pain stimuli presented here, and consequently, a higher saliency [10, 12]. 21 
However, it could also be related to the lower levels of evoked itch than pain. Reversely, participants 22 
may have better been able to ignore the itch and therefore perceived itch less intense during the 23 
attention task, akin previous findings showing that focusing away from pain can result in less intense 24 
pain [28, 57]. Support for this explanation comes from the large decline in itch when comparing the itch 25 
stimuli, at the same intensity, given at baseline and during the attention task. Another possible 26 
explanation could be that people habituate more easily to itch than to pain, but this has, to our 27 
knowledge, not yet been investigated. 28 
Of the psychological characteristics the individual level of catastrophizing of physical sensations and 29 
neuroticism were related to a higher attentional bias index for itch. However, given the non-significant 30 
association between catastrophizing and the attentional bias index for pain, these findings should be 31 
interpreted with caution. There were also some indications that higher perceived threat of the itch 32 
17 
 
stimulus was related to a higher attentional bias index for itch, but higher perceived threat of the pain 1 
stimulus was associated with a lower attentional bias index for pain, which is contrary to what would be 2 
expected. Other psychological characteristics, including fear of pain, self-reported attention to and 3 
disengagement from physical sensations and itch and pain in particular, did not play a role in attention 4 
allocation towards the itch and pain stimuli. Future research should further investigate the role of 5 
individual characteristics in spatial attention allocation towards itch and pain.  6 
This study has several limitations. First, the levels of itch induced during the attention task were 7 
relatively low and not directly comparable to pain. Second, after each block in the SAT, participants 8 
retrospectively rated the intensity of itch and pain during the somatosensory stimulation. It cannot be 9 
ruled out that participants also intentionally focused on the stimulation while responding to the visual 10 
targets. Third, the current design did not allow the investigation of fast attentional switches between 11 
somatosensory and visual stimuli. Future research may use more fine-grained time segments. Fourth, 12 
the included group was homogenous with respect to age, but has the disadvantage that extrapolation to 13 
other age groups is limited.  14 
 15 
 16 
5. Conclusions 17 
 18 
This study showed that, although tonic itch and pain stimuli interfere with task performance, these do 19 
not prioritize attention is not consistently drawn towards their spatial location, probably because 20 
attention shifts over the time course of tonic stimuli. Additional research focusing more closely on time 21 
aspects of attention allocation is required to elucidate how tonic itch and pain stimuli are being 22 
processed in healthy participants and in clinical populations. When focusing attention on the location of 23 
itch or pain aggravates symptoms, patients with chronic itch and pain may benefit from learning to 24 
disengage their attention away from itch or pain, respectively. 25 
 26 
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TABLES 1 
 2 
Table 1 Total scores of self-reported questionnaires (n=53)  3 
 Mean score ± SD Range 
Level of spontaneous itch at baseline 0.2 ± 0.5  0.0 – 2.0 
Level of spontaneous pain at baseline 0.2 ± 0.4  0.0 – 2.0 
Level of fatigue at baseline 1.8 ± 1.3 0.0 – 5.5 
Affect   
 Anxiety (HADS-Anxiety) 2.4 ± 0.5 0.9 – 3.0 
 Depression (HADS-Depression) 2.7 ± 0.3 1.9 – 3.0 
Personality characteristics    
 Neuroticism (EPQ-RSS) 3.2 ± 2.5 0 – 11 
Attention to bodily sensations   
 Attentional focus on itch 2.2 ± 1.9 0 - 6.5  
 Attentional focus on pain 3.3 ± 2.4 0 - 8.0  
 BVS 2.8 ± 1.5 0.2 – 6.8 
 BSQ 2.0 ± 0.5 1.3 – 3.3 
 PVAQ-A 24.2 ± 9.5 4 – 45 
Catastrophizing   
 PCS-A 7.5 ± 6.4 0 – 29 
Fear of pain   
 FPQ-III 63.3 ± 15.9 36 - 101 
Attentional disengagement from   
 Itch 4.3 ± 1.0 1 – 5 
 Pain 4.0 ± 0.9 1 – 5 
Abbreviations: HADS: Hospital Anxiety and Depression Scale (theoretical range 0–21 per subscale); EPQ-4 
RSS: Eysenck Personality Questionnaire revised short scale (theoretical range 0-12 neuroticism subscale); 5 
Single items assessing attentional focusing on itch and pain (theoretical range 0-10); BVS: Body Vigilance 6 
Scale (theoretical range 0-10); BSQ: Body Sensations Questionnaire (theoretical range 1-5); PVAQ-A: Pain 7 
Vigilance and Awareness Scale, adjusted for physical sensations (theoretical range 0-80); PCS-A: Pain 8 
Catastrophizing Scale, adjusted for physical sensations (theoretical range 0-52); FPQ: Fear of pain 9 
questionnaire (theoretical range 30-150); Single items about attentional disengagement (theoretical 10 
range 1-5).  11 
 12 
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Table 2 Means ± standard deviations of NRS itch, pain, and unpleasantness scores at baseline and during 1 
the pain, itch and control blocks of the somatosensory attention task (SAT) (n=51) 2 
 NRS itch NRS pain NRS unpleasantness 
Baseline itch stimulus 3.5 ± 2.2 0.6 ± 1.1 2.3 ± 2.0 
Baseline pain stimulus 0.9 ± 1.3 3.9 ± 1.7 3.4 ± 1.8 
    
SAT itch blocks 1.8 ± 1.6 0.2 ± 0.4 1.2 ± 1.5 
SAT pain blocks 0.5 ± 0.8 3.0 ± 1.7 2.7 ± 1.7 
SAT control blocks 0.1 ± 0.2 0.0 ± 0.1 0.0 ± 0.1 
Note: the electrical current at which the itch and pain stimuli were applied was tailored to individual 3 
sensitivity and was identical during baseline measurements and the SAT.  4 
 5 
 6 
 7 
 8 
 9 
 10 
Table 3 Mean reaction times (in ms) ± standard deviation for the ipsilateral and contralateral trials of the 11 
somatosensory attention task (SAT) during itch, pain, and control blocks (n=51) 12 
 Ipsilateral trials (ms) Contralateral trials (ms) 
Itch blocks 466.2 ± 91.0 463.7 ± 84.4 
Pain blocks 470.7 ± 81.8 472.5 ± 80.9 
Control blocks 450.4 ± 81.21 457.4 ± 88.52 
1 Reaction times during control blocks (no somatosensory stimulation) ipsilateral to attached itch 13 
electrodes location 14 
2 Reaction times during control blocks (no somatosensory stimulation) ipsilateral to the attached pain 15 
electrodes location 16 
  17 
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 1 
FIGURES 2 
 3 
Fig. 1: Schematic representation of the setup of the somatosensory attention task. The side of itch 4 
stimulation was contralateral to the pain stimulation (randomized across participants). During a block, an 5 
itch (itch block) or pain (pain block) stimulus is being applied, or no stimulation (control blocks), while, 6 
after short onset of the fixation light, one of the target lights is illuminated. Participants respond to the 7 
target light location using response buttons right below both target lights, either at the ipsilateral or 8 
contralateral location as opposed to the somatosensory stimulation. 9 
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 1 
 2 
Fig. 2: Reaction times (in ms) for participants’ (n=51) responding to the visual target lights during the 35-s 3 
somatosensory itch (Fig. 2A) or pain bocks (Fig. 2B) or in control blocks, in which no somatosensory 4 
stimulation was applied (Fig. 2C). Visual targets were either displayed at the side of the itch or pain 5 
stimulation cq. attachment of the itch or pain electrodes in the case of the control blocks (i.e. ipsilateral 6 
trials – solid line) or at the opposite side (i.e. contralateral trials – dashed line).  7 
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